By Katherine Hamilton
Broadcom expects revenue in the current quarter ahead of expectations thanks to growing AI demand. The stock advanced 5% to $332.82 in after-hours trading Wednesday.
StubHub swung to a loss and posted lower revenue as it invests in AI to build a supply management platform. Shares slid 12% to $8.97 after the bell.
PepGen said the FDA is pausing a trial of its myotonic dystrophy treatment. The stock shed 19% to $5.50.
Veeva Systems' revenue and profit rose. Shares gained 13% to $212.76.
Write to Katherine Hamilton at katherine.hamilton@wsj.com
(END) Dow Jones Newswires
March 04, 2026 18:24 ET (23:24 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.